CLOV vs DLX · rev $1.37B vs P/E 13, rev $2.12B
Clover Health Investments Corp (CLOV) versus Deluxe Corporation (DLX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Deluxe Corporation (DLX) is a conglomerates company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported DLX revenue for 2024-12-31 was $2.12B. Net income was $52.9M. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. DLX currently screens at market cap $709.7M and trailing P/E 12.7.
CLOV currently screens at market cap $1.55B. DLX currently screens at market cap $709.7M and trailing P/E 12.7.
Not investment advice. Open the CLOV and DLX stock pages for the full models.
Not investment advice.